Clinical Trial

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Protocol Amendment History 33 amendments
This ClinicalTrials.gov record has been amended 33 times since 2023-05-25; most recent amendment 2026-05-19.
Status change: Not Yet Recruiting → Recruiting 2023-07-24
Trial Details
NCT Number NCT05890729
Lead Sponsor Xentria, Inc.
Conditions Pulmonary Sarcoidosis
Enrollment 94 participants
Start Date 2023-11-10
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-20